Please note we strongly recommend to our authors writing about SARS-CoV-2 that they follow WHO approved nomenclature for variant strains. We recommend the Pango nomenclature, but GISAID and Nexstrain are also approved.

npj Vaccines has a 2-year impact factor of 7.0 (2023), with 2,006,126 article downloads in 2024 and 11 days from submission to first editorial decision (2024).

Therapeutic Human papillomavirus (HPV) vaccines are considered to be a promising approach to intercept the development of HPV-driven cancers in already HPV-infected people. This collection aims to gather the state of the art of therapeutic HPV vaccine research – from novel vaccine design concepts, to preclinical models, to results of clinical trials.

This collection invites research on veterinary vaccines with a special focus on One Health in all its dimensions. It extends from protecting human health through pathogen control and elimination in the reservoir hosts to reduction of antibiotics use and the generation of real world evidence for innovative vaccine concepts and technologies.